Simplex Trading’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.7K | Sell |
10,589
-10,306
| -49% | -$14.2K | ﹤0.01% | 7011 |
|
|
2025
Q4 | $33.6K | Sell |
20,895
-79,208
| -79% | -$166K | ﹤0.01% | 6014 |
|
|
2025
Q3 | $273K | Sell |
100,103
-92,931
| -48% | -$309K | ﹤0.01% | 4591 |
|
|
2025
Q2 | $702K | Buy |
193,034
+54,564
| +39% | +$150K | ﹤0.01% | 3162 |
|
|
2025
Q1 | $265K | Buy |
138,470
+9,488
| +7% | +$19.4K | ﹤0.01% | 4042 |
|
|
2024
Q4 | $245K | Buy |
+128,982
| New | +$224K | ﹤0.01% | 4297 |
|
|
2022
Q2 | – | Sell |
-86,989
| Closed | -$36.5K | – | 9841 |
|
|
2022
Q1 | $62K | Buy |
86,989
+31,954
| +58% | +$68.4K | ﹤0.01% | 6826 |
|
|
2021
Q4 | $124K | Buy |
+55,035
| New | +$150K | ﹤0.01% | 5908 |
|
|
2021
Q2 | – | Sell |
-48,118
| Closed | -$162K | – | 9947 |
|
|
2021
Q1 | $162K | Sell |
48,118
-52,704
| -52% | -$190K | ﹤0.01% | 5058 |
|
|
2020
Q4 | $282K | Buy |
100,822
+3,373
| +3% | +$9.85K | ﹤0.01% | 4157 |
|
|
2020
Q3 | $244K | Buy |
97,449
+52,801
| +118% | +$463K | ﹤0.01% | 3857 |
|
|
2020
Q2 | $606K | Sell |
44,648
-71,938
| -62% | -$744K | ﹤0.01% | 2682 |
|
|
2020
Q1 | $883K | Sell |
116,586
-8,094
| -6% | -$63K | ﹤0.01% | 2002 |
|
|
2019
Q4 | $787K | Buy |
124,680
+106,689
| +593% | +$507K | ﹤0.01% | 2306 |
|
|
2019
Q3 | $70K | Sell |
17,991
-31,856
| -64% | -$137K | ﹤0.01% | 4693 |
|
|
2019
Q2 | $241K | Buy |
49,847
+13,357
| +37% | +$76K | ﹤0.01% | 3279 |
|
|
2019
Q1 | $298K | Buy |
+36,490
| New | +$250K | ﹤0.01% | 3207 |
|
|
2018
Q4 | – | Sell |
-33,863
| Closed | -$265K | – | 6910 |
|
|
2018
Q3 | $299K | Sell |
33,863
-14,655
| -30% | -$131K | ﹤0.01% | 3182 |
|
|
2018
Q2 | $484K | Buy |
48,518
+46,743
| +2,633% | +$468K | ﹤0.01% | 2491 |
|
|
2018
Q1 | $16K | Sell |
1,775
-346
| -16% | -$4.84K | ﹤0.01% | 3548 |
|
|
2017
Q4 | $31K | Sell |
2,121
-320
| -13% | -$5.31K | ﹤0.01% | 2873 |
|
|
2017
Q3 | $48K | Buy |
2,441
+1,841
| +307% | +$28.3K | ﹤0.01% | 2334 |
|
|
2017
Q2 | $8K | Sell |
600
-3,354
| -85% | -$42.5K | ﹤0.01% | 4130 |
|
|
2017
Q1 | $36K | Sell |
3,954
-23,178
| -85% | -$226K | ﹤0.01% | 2658 |
|
|
2016
Q4 | $282K | Buy |
27,132
+4,560
| +20% | +$39.3K | 0.02% | 834 |
|
|
2016
Q3 | $204K | Buy |
22,572
+5,567
| +33% | +$47.3K | 0.01% | 1024 |
|
|
2016
Q2 | $127K | Buy |
17,005
+6,908
| +68% | +$60.3K | 0.01% | 1301 |
|
|
2016
Q1 | $90K | Buy |
10,097
+7,950
| +370% | +$64.5K | 0.01% | 1443 |
|
|
2015
Q4 | $27K | Sell |
2,147
-31,001
| -94% | -$316K | ﹤0.01% | 2433 |
|
|
2015
Q3 | $320K | Buy |
+33,148
| New | +$304K | 0.02% | 653 |
|
Other funds holding AKBA
VCM
VPM
Simplex Trading's AKBA Position: Q1 2026 in Review
Simplex Trading reduced its Akebia Therapeutics (AKBA) stake by 49% in Q1 2026, selling an estimated $14.2K and leaving 10,589 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7011.
Simplex Trading first reported a position in AKBA in Q3 2015 and has held it in 30 quarters since. The position peaked at $883K in Q1 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.
- Simplex Trading held 10,589 shares of Akebia Therapeutics worth $14.7K as of Q1 2026.
- Simplex Trading sold 10,306 Akebia Therapeutics shares in Q1 2026, an estimated $14.2K.
- Akebia Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7011 holding.
- Simplex Trading first reported a position in Akebia Therapeutics in Q3 2015 and has held it in 30 quarters since.
- Simplex Trading's Akebia Therapeutics position peaked at $883K in Q1 2020.
- 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.